These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3233685)

  • 21. Theophylline in the treatment of the elderly with chronic obstructive pulmonary disease.
    Antognozzi G; Buzzo P; Mori M; Ellena S; Triolo A
    Riv Eur Sci Med Farmacol; 1994; 16(3-4):69-72. PubMed ID: 7480962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid estimation of total body clearance of theophylline in patients receiving intravenous aminophylline infusion.
    Lau AH; O'Connor T; Lam G; Lui CY; Al-Bazzaz FJ; Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):12-5. PubMed ID: 3957483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controversies in pulmonary medicine. Aminophylline should be administered for all acute exacerbations of COPD.
    Ziment I; Niewoehner DE
    Am Rev Respir Dis; 1988 Oct; 138(4):1070. PubMed ID: 3202440
    [No Abstract]   [Full Text] [Related]  

  • 24. [Analysis of combined therapy in exacerbation of chronic obstructive pulmonary disease].
    Remskar Z; Jerse M
    Plucne Bolesti; 1986; 38(1):12-5. PubMed ID: 3786547
    [No Abstract]   [Full Text] [Related]  

  • 25. Maintenance of bronchodilation in chronic reversible airways obstruction. Comparison between choline theophyllinate and salbutamol.
    Tanser AR
    Practitioner; 1982 Mar; 226(1365):569-71. PubMed ID: 7045848
    [No Abstract]   [Full Text] [Related]  

  • 26. Stability of pulmonary function during periodic intravenous bolus aminophylline therapy.
    Koup JR; Brodsky B
    Ther Drug Monit; 1979; 1(1):85-91. PubMed ID: 553333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnesium sulfate in exacerbations of chronic obstructive pulmonary disease.
    Skorodin MS; Tenholder MF; Yetter B; Owen KA; Waller RF; Khandelwahl S; Maki K; Rohail T; D'Alfonso N
    Arch Intern Med; 1995 Mar; 155(5):496-500. PubMed ID: 7864705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy of high-dose beclomethasone in patients with stable chronic obstructive pulmonary disease].
    Koyama H; Nishimura K; Ikeda A; Tsukino M; Izumi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Apr; 33(4):410-5. PubMed ID: 7791269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of sustained-release theophylline ('Theo-dur') for the treatment of chronic reversible obstructive lung disease in hospital practice.
    Riddington CJ; Shipman AJ
    Br J Clin Pract; 1985 Apr; 39(4):148-53. PubMed ID: 3893504
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.
    Jenne JW; Wyze MS; Rood FS; MacDonald FM
    Clin Pharmacol Ther; 1972; 13(3):349-60. PubMed ID: 5026376
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetic disposition of theophylline in horses after intravenous administration.
    Kowalczyk DF; Beech J; Littlejohn D
    Am J Vet Res; 1984 Nov; 45(11):2272-5. PubMed ID: 6524719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bronchodilator effects on gastric acid secretion.
    Foster LJ; Trudeau WL; Goldman AL
    JAMA; 1979 Jun; 241(24):2613-5. PubMed ID: 439357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The safety and tolerability of adenosine in patients with obstructive airways disease.
    van Gaal WJ; Couthino B; Chan M; Allman KC
    Int J Cardiol; 2008 Aug; 128(3):436-8. PubMed ID: 17655953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Double-blind crossover study on the long-term effects of aminophylline retard tablets on the use of salbutamol aerosol spray].
    Brändli O; Langloh P
    Schweiz Rundsch Med Prax; 1982 Oct; 71(40):1553-8. PubMed ID: 6757909
    [No Abstract]   [Full Text] [Related]  

  • 35. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
    Majumdar S; Sen S; Mandal SK
    J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Almitrine bismesylate: a long-term placebo-controlled double-blind study in COAD--Vectarion International Multicentre Study Group.
    Voisin C; Howard P; Ansquer JC
    Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():169s-182s. PubMed ID: 3318971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects on diffusing capacity and ventilation--perfusion relationships of budesonide inhalations for 2 months in chronic obstructive pulmonary disease (COPD).
    Sandek K; Bratel T; Lagerstrand L
    Respir Med; 2001 Aug; 95(8):676-84. PubMed ID: 11530957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing the airways.
    Enright P; McCormack M
    Chron Respir Dis; 2008; 5(2):115-9. PubMed ID: 18539726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypokalaemic and electrocardiographic effects of aminophylline and salbutamol in obstructive airways disease.
    Crane J; Burgess CD; Graham AN; Maling TJ
    N Z Med J; 1987 May; 100(824):309-11. PubMed ID: 3330186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of aminophylline upon the exercise performance of patients with stable chronic airflow obstruction.
    Nietrzeba RM; Elliott CG; Adams TD; Yeh MP; Yanowitz FG
    Bull Eur Physiopathol Respir; 1984; 20(4):361-7. PubMed ID: 6478093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.